Detalles de la búsqueda
1.
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.
Clin Exp Immunol
; 181(2): 362-72, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25846055
Resultados
1 -
1
de 1
1
Próxima >
>>